The role of macrophages in chronic arthritis

Immunobiology

Volumn 195, Issue 4-5, 1996, Pages 614-623

  Van Den Berg, Wim B ^a,b   Van Lent, Peter L E M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Rheumatology Research Lab   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

BONE DEFECT; CARTILAGE DEGENERATION; CONFERENCE PAPER; HUMAN; MACROPHAGE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIUM;

EID: 0029810201     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(96)80026-X     Document Type: Conference Paper

References (19)

1. FIRESTEIN, G. S., J. S. ALVARO-GARCIA, and R. MAKI. 1990. Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J. Immunol. 144: 3347.
2. FIRESTEIN, G. S., and N. J. ZVAIFLER. 1994. How important are T cells in chronic arthritis. Lancet 344: 1105.
3. BRENNAN, F. M., D. CHANTRY, A. JACKSON, R. N. MAINI, and M. FELDMANN. 1989. Inhibitory effect of TNFα antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 2: 244.
4. ELLIOTT, M. J., R. N. MAINI, M. FELDMANN, J. R. KALDEN, C. ANTONI, J. SMOLEN, B. LEEB, E. C. BREEDVELD, J. D. MACFARLANE, H. BIJL, and J. N. WOODY. 1994. Randomised double-blind comparison of chimeric monoclonal antibody to TNFα versus placebo in rheumatoid arthritis. Lancet 344: 1105.
5. VAN DE LOO, A. A. J., L. A. B. JOOSTEN, P. L. E. M. VAN LENT, O. J. ARNTZ, and W. B. VAN DEN BERG. 1995. Role of Interleukin-1, Tumor Necrosis Factor α and Interleukin-6 in cartilage proteoglycan metabolism and destruction. Effect of in situ cytokine blocking in murine antigen- and zymosan-induced arthritis. Arthritis Rheum. 38: 164.
6. VAN DE LOO, A. A. J., O. J. ARNTZ, A. C. BAKKER, P. L. E. M. VAN LENT, M. J. M. JACOBS, and W. B. VAN DEN BERG. 1995. Role of Interleukin-1 in antigen-induced exacerbations of murine arthritis. Am. J. Pathol. 146: 239.
7. VAN DEN BERG, W. B., L. A. B. JOOSTEN, M. M. A. HELSEN, and A. A. J. VAN DE LOO. 1994. Amelioration of established murine collagen induced arthritis with anti-IL-1 treatment. Clin. Exp. Immunol. 95: 237.
8. VAN LENT, P. L. E. M., F. A. J. VAN DE LOO, A. E. M. HOLTHUYSEN, L. A. M. VAN DEN BERSSELAAR, H. VERMEER, and W. B. VAN DEN BERG. 1995. Major role for IL-1 but not for TNF in early cartilage damage in immune complex arthritis in mice. J. Rheumatol. 22: 2250.
9. PROBERT, L., D. PLOWS, G. KONTOGEORGOS, and G. KOLLIAS. 1995. The type I interleukin receptor acts in series with TNF to induce arthritis in TNF-transgenic mice. Eur. J. Immunol. 25: 1794.
10. WIKTOR-JEDREZJCZAK, W., A. BARTOCCI, and A. W. FERRANTE. 1990. Total absence of colony stimulating factor 1 in the macrophage deficient osteopetrotic (op/op) mouse. Proc. Natl. Acad. Sci. USA 87: 4828.
11. VAN LENT, P. L. E. M., A. E. M. HOLTHUYSEN, L. VAN DEN BERSSELAAR, N. VAN ROOIJEN, L. B. A. VAN DE PUTTE, and W. B. VAN DEN BERG. 1995. Role of macrophage-like synovial lining cells in localization and expression of experimental arthritis. Scand. J. Rheumatol. 24 (Suppl. 101): 83.
12. VAN LENT, P. L. E. M., A. E. M. VAN DEN HOEK, L. VAN DEN BERSSELAAR, C. D. DIJKSTRA, N. VAN ROOIJEN, and W. B. VAN DEN BERG. 1992. Role of synovial macrophages in experimental arthritis. Res. Immunol. 143: 229.
13. VAN LENT, P. L. E. M., A. E. M. VAN DEN HOEK, L. A. M. VAN DEN BERSSELAAR, M. F. R. SPANJAARDS, N. VAN ROOIJEN, C. D. DIJKSTRA, L. B. A. VAN DE PUTTE, and W. B. VAN DEN BERG. 1993. In vivo role of phagocytic lining cells in onset of experimental arthritis. Am. J. Pathol. 143: 1226.
14. VAN LENT, P. L. E. M., L. VAN DEN BERSSELAAR, A. E. M. VAN DEN HOEK, M. VAN DE ENDE, C. D. DIJKSTRA, N. VAN ROOIJEN, L. B. A. VAN DE PUTTE, and W. B. VAN DEN BERG. 1993. Reversible depletion of synovial lining cells after intra-articular treatment with liposome-encapsulated dichloromethylene diphosphonate. Rheumatol. Int. 13: 21.
15. VAN DE LOO, A. A. J., O. J. ARNTZ, and W. B. VAN DEN BERG. 1992. Flare up of experimental arthritis in mice with murine recombinant IL-1. Clin exp Immunol. 87: 196.
16. VAN BEUNINGEN, H. M., P. M. VAN DER KRAAN, O. J. ARNTZ, and W. B. VAN DEN BERG. 1994. In vivo protection against interleukin-1-induced articular cartilage damage by transforming growth factor-β1: age related differences. Ann. Rheum. Dis. 53: 593.
17. VAN DE LOO, A. A. J., O. J. ARNTZ, I. G. OTTERNESS, and W. B. VAN DEN BERG. 1992. Protection against cartilage proteoglycan synthesis inhibition by anti-interleukin 1 antibodies in experimental arthritis. J. Rheumatol. 19: 348.
18. GAY, S., R. E. GAY, and W. J. KOOPMAN. 1993. Molecular and cellular mechanisms of joint destruction in RA: Two cellular mechanisms explain joint destruction? Ann. Rheum. Dis. 52: S39.
19. MÜLLER-LADNER, U., J. KRIEGSMANN, R. E. GEILER, R. E. GAY, and S. GAY. 1995. Synovial mesenchymal reaction as a perpetuating principle. Scand. J. Rheumatol. 24 (Suppl 101): 115.